1.
Rev Neurol
; 27(159): 827-30, 1998 Nov.
Artículo
en Español
| MEDLINE
| ID: mdl-9859160
RESUMEN
The HMG-CoA reductase inhibitors (known as statins) have been shown to reduce morbi-mortality of vascular origin, including transitory ischemic accidents and cerebral infarcts, in a large group of patients. The implications, both clinical and of costs, oblige us to consider analysis of the existing evidence and the answers to a number of questions arising in a field which has not yet received much attention from neurologists.